Clinical Research Directory
Browse clinical research sites, groups, and studies.
Biomarkers of CASH
Sponsor: University of Chicago
Summary
The project aims to develop prognostic and diagnostic blood tests for symptomatic brain hemorrhage in patients diagnosed with cavernous angiomas, a critical clinical challenge in a disease affecting more than a million Americans. We further examine whether blood biomarkers can replace or enhance the accuracy of advanced imaging in association with lesional bleeding. The project tests a novel integrational approach of biomarker development in a mechanistically defined cerebrovascular disease, with a clinically relevant context of use.
Official title: Biomarkers of Cerebral Cavernous Angioma With Symptomatic Hemorrhage (CASH)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1040
Start Date
2020-05-22
Completion Date
2026-06-30
Last Updated
2025-08-11
Healthy Volunteers
Yes
Interventions
observational
There is no intervention for any group in this observational study.
Locations (4)
Barrow Neurological Institute at St. Joseph's Hospital and Medical Center
Phoenix, Arizona, United States
University of California, San Francisco
San Francisco, California, United States
The University of Chicago Medical Center
Chicago, Illinois, United States
Mayo Clinic
Rochester, Minnesota, United States